Cargando…

The 5q31 variants associated with psoriasis and Crohn's disease are distinct

Predisposition to psoriasis is known to be affected by genetic variation in HLA-C, IL12B and IL23R, but other genetic risk factors also exist. We recently reported three psoriasis-associated single nucleotide polymorphisms (SNPs) in the 5q31 locus, a region of high linkage disequilibrium laden with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yonghong, Chang, Monica, Schrodi, Steven J., Callis-Duffin, Kristina P., Matsunami, Nori, Civello, Daniel, Bui, Nam, Catanese, Joseph J., Leppert, Mark F., Krueger, Gerald G., Begovich, Ann B.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2008
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536504/ https://www.ncbi.nlm.nih.gov/pubmed/18614543 http://dx.doi.org/10.1093/hmg/ddn196

Ejemplares similares

Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis
por: Feng, Bing-Jian, et al.
Publicado: (2009)

The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA
por: Walsh, Jessica A, et al.
Publicado: (2018)

Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series
por: Brummer, Grace C., et al.
Publicado: (2017)

Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways
por: Nair, Rajan P., et al.
Publicado: (2009)

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies
por: Callis Duffin, Kristina, et al.
Publicado: (2019)

Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry
por: Armstrong, April W., et al.
Publicado: (2022)

Real-World Effectiveness of 9–12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry
por: Armstrong, April W., et al.
Publicado: (2022)

Demographics, Disease Characteristics, and Patient-Reported Outcomes Among Patients with Psoriasis Who Initiated Guselkumab in CorEvitas’ Psoriasis Registry
por: Walsh, Jessica A., et al.
Publicado: (2021)

Feasibility and Utility of the Psoriasis Symptom Inventory (PSI) in Clinical Care Settings: A Study from the International Psoriasis Council
por: Strober, Bruce, et al.
Publicado: (2019)

Neither Replication nor Simulation Supports a Role for the Axon Guidance Pathway in the Genetics of Parkinson's Disease
por: Li, Yonghong, et al.
Publicado: (2008)

Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility
por: Yin, Xianyong, et al.
Publicado: (2015)

Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations
por: Chang, Hsin-Wen, et al.
Publicado: (2022)

A Large-Scale Rheumatoid Arthritis Genetic Study Identifies Association at Chromosome 9q33.2
por: Chang, Monica, et al.
Publicado: (2008)

Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients
por: Patrick, Matthew T., et al.
Publicado: (2018)

Prenatal diagnosis of a novel 7q31.31q31.33 microduplication with a favorable outcome
por: Luo, Huili, et al.
Publicado: (2022)

Significance of interleukin-31 (IL-31) gene polymorphisms and IL-31 serum level in psoriasis in correlation with pruritus
por: Purzycka-Bohdan, Dorota, et al.
Publicado: (2021)

Infliximab-induced intertriginous psoriasis in patient with Crohn's disease
por: Mola, Federica, et al.
Publicado: (2011)

Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer
por: Neklason, Deborah W, et al.
Publicado: (2010)

Mapping DNA interaction landscapes in psoriasis susceptibility loci highlights KLF4 as a target gene in 9q31
por: Ray-Jones, Helen, et al.
Publicado: (2020)

Pure interstitial dup(6)(q22.31q22.31) – a case report
por: Sheth, Frenny, et al.
Publicado: (2015)

Infantile spasms related to a 5q31.2-q31.3 microdeletion including PURA
por: Shimojima, Keiko, et al.
Publicado: (2018)

Factor V Leiden and Thrombosis in Patients with Systemic Lupus Erythematosus (SLE): A Meta-analysis
por: Kaiser, R., et al.
Publicado: (2009)

Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Phase 3, open‐label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate‐to‐severe plaque psoriasis (UNCOVER‐A)
por: Callis Duffin, K., et al.
Publicado: (2016)

IL-33/13 Axis and IL-4/31 Axis Play Distinct Roles in Inflammatory Process and Itch in Psoriasis and Atopic Dermatitis
por: Bodoor, Khaldon, et al.
Publicado: (2020)

Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis Vulgaris
por: Bissonnette, Robert, et al.
Publicado: (2016)

Long-term follow-up of a patient with 5q31.3 microdeletion syndrome and the smallest de novo 5q31.2q31.3 deletion involving PURA
por: Bonaglia, Maria Clara, et al.
Publicado: (2015)

Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review
por: Mohammed, Reem Hamdy A, et al.
Publicado: (2023)

Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn’s Disease
por: Darwin, Evan, et al.
Publicado: (2018)

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants
por: Tsoi, Lam C., et al.
Publicado: (2017)

Interstitial deletion within 7q31.1q31.3 in a woman with mild intellectual disability and schizophrenia
por: Akahoshi, Keiko, et al.
Publicado: (2018)

Ulcerative Colitis and Crohn's Disease: Similarities and Distinctions
por: Sawyerr, Af M, et al.
Publicado: (1994)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction
por: Yan, Bing-Xi, et al.
Publicado: (2021)

Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31
por: Park, Sung-Min, et al.
Publicado: (2020)

A 9.8 Mb deletion at 7q31.2q31.31 downstream of FOXP2 in an individual with speech and language impairment suggests a possible positional effect
por: Iwata‐Otsubo, Aiko, et al.
Publicado: (2022)

Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region
por: Ferreira, Susana Isabel, et al.
Publicado: (2012)

A Case of 17q21.31 Microduplication and 7q31.33 Microdeletion, Associated with Developmental Delay, Microcephaly, and Mild Dysmorphic Features
por: Mc Cormack, Adrian, et al.
Publicado: (2014)

Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
por: Ju, Jingyi, et al.
Publicado: (2020)

Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis
por: Barahimi, Mitra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bs3ju7i3erk7op2hq219kalvnj